CN Patent

CN120360964A — 较高剂量的改良释放石杉碱制剂的用途

Assigned to Supernus Pharmaceuticals Inc · Expires 2025-07-25 · 1y expired

What this patent protects

本发明的发明名称是较高剂量的改良释放石杉碱制剂的用途。本申请公开了药物组合物和用石杉碱的高剂量改良释放组合物治疗神经系统病症和癫痫发作病症的方法。本文所述的药物组合物和方法允许石杉碱的较高剂量给药，同时避免快速峰值血浆水平，从而避免与立即释放制剂相关的剂量限制性不良事件。

USPTO Abstract

本发明的发明名称是较高剂量的改良释放石杉碱制剂的用途。本申请公开了药物组合物和用石杉碱的高剂量改良释放组合物治疗神经系统病症和癫痫发作病症的方法。本文所述的药物组合物和方法允许石杉碱的较高剂量给药，同时避免快速峰值血浆水平，从而避免与立即释放制剂相关的剂量限制性不良事件。

Drugs covered by this patent

Patent Metadata

Patent number
CN120360964A
Jurisdiction
CN
Classification
—
Expires
2025-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Supernus Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.